A study by Gallay et al (2009), showed that 24 out of 53 AML patients had high AKT phosphorylation on t308 and this (but not AKT phosphorylation on s473) was associated with high-risk cytogenetics and predicted poor overall survival in AML [37]. Here, AKT1 is linked to acute myeloid leukemia.